Goldman Sachs Group Inc Eyenovia, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.52 - $1.06 $179,098 - $365,085	344,420 Added 1938.97%	362,183 $213,000
Q1 2024 May 15, 2024	SELL	$0.99 - $2.37 $4,135 - $9,899	-4,177 Reduced 19.04%	17,763 $17,000
Q4 2023 Feb 13, 2024	SELL	$1.08 - $2.08 $366,696 - $706,230	-339,534 Reduced 93.93%	21,940 $45,000
Q3 2023 May 14, 2024	BUY	$1.57 - $2.54 $533,068 - $862,416	339,534 Added 1547.56%	361,474 $600,000
Q3 2023 Nov 14, 2023	BUY	$1.57 - $2.54 $549,025 - $888,232	349,698 Added 2969.58%	361,474 $600,000
Q2 2023 May 14, 2024	SELL	$2.21 - $5.75 $22,462 - $58,443	-10,164 Reduced 46.33%	11,776 $27,000
Q2 2023 Aug 14, 2023	BUY	$2.21 - $5.75 $26,024 - $67,712	11,776 New	11,776 $27,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $2.74M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.